Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Wound
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
RatWoundCrl:CD(SD)Malen = 4 to 5 rats per group in the disc implantation experiments;…Topical to the wound; subcutaneous implantation for the disc model0.2 mg/ml in 50 microlitres for the diabetic flap model; 1…From the time of wounding, with bacteria applied on days 0 to 3 in the infected…
Model: Full-thickness skin defect with flap in streptozotocin-induced diabetic rats; full-thickness wound inoculated with Staphylococcus aureus in cyclophosphamide-treated rats; incised wound and paper disc implantation models
SR-0379 significantly accelerated wound closure compared with fibroblast growth factor 2 in both the diabetic flap model and the Staphylococcus aureus-infected full-thickness model, with enhanced angiogenesis, granulation tissue formation and proliferation of endothelial cells and fibroblasts along…
Extraction: extract · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.